Delivery Order SPE2DB20D2014-SPE2DB25FC88V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $8,590.58 and an ultimate completion date of August 8, 2025. The contract was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in a quantity of 60 units, with a ceiling value of $8,630.28. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. The contract is valued at $8,590.58 and represents a firm fixed price delivery order with an ultimate completion date of September 16, 2025. This award is non-set-aside and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, valued at $8,590.58 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made without a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, with a ceiling value of $8,590.58 and firm fixed pricing. This delivery order is non-set-aside and represents a competitive award under the company's broader pharmaceutical supply agreement with DLA. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 23,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ofev 100 mg capsules (60-count) with a ceiling value of $8,630.28. This firm fixed-price delivery order is set to be completed by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, demonstrating AmerisourceBergen's continued capability to meet federal...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract carries an ultimate completion date of August 27, 2025, and performance will be executed from the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units, with a ceiling value of $8,590.58. This competitively awarded, non-set-aside delivery order employs firm fixed price terms and is scheduled for ultimate completion on June 23, 2025, following the award date of May 30, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, valued at $8,590.58. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and was awarded on August 22, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $68,724.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by October 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC88VDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in a 60-count unit, with a contract ceiling value of $17,260.58. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 24, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contracts supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal procurement capabilities have been validated through consistent competitive awards and demonstrated ability to fulfill diverse medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 9/3/25 |